NCT05269381
- Conditions
- Adenocarcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +165 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
Clinical trial condition
Locally Advanced Gastroesophageal Junction Adenocarcinoma
Explore clinical trials studying Locally Advanced Gastroesophageal Junction Adenocarcinoma. Study availability and eligibility vary by location and protocol.
8 public trials
5 recruiting studies
Locally Advanced Gastroesophageal Junction Adenocarcinoma trial results
NCT06364410
- Conditions
- Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IV Gastric Cancer AJCC v8, +22 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
NCT04511039
- Conditions
- Advanced Malignant Solid Neoplasm, Clinical Stage III Gastroesophageal Junction Adenocarcinoma, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma, +37 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT05651594
- Conditions
- Adenocarcinoma Of Esophagus, Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, +9 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT04989985
- Conditions
- Chemotherapy Effect, Locally Advanced Gastroesophageal Junction Adenocarcinoma
- Locations
-
- The sixth affiliated hospital of Sun Yat-sen University Guangzhou, Guangdong, China
Not Yet Recruiting
Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
NCT07594548
- Conditions
- Adenocarcinoma Of Esophagus, Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, +14 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
- Ohio State University Columbus, Ohio, United States
Active, Not Recruiting
Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors
NCT04007744
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +49 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Active, Not Recruiting
Pembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal Cancer
NCT04522336
- Conditions
- Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8, +16 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Related conditions
- Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 (6)
- Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 (6)
- Metastatic Gastroesophageal Junction Adenocarcinoma (6)
- Clinical Stage III Gastric Cancer AJCC v8 (4)
- Clinical Stage IV Gastric Cancer AJCC v8 (4)
- Neoplasms (4)
- Neoplasms by Site (4)
- Unresectable Gastroesophageal Junction Adenocarcinoma (4)